Investment

EPC, EPO, European Union, Germany, Investment, Litigation, Pharma, Pharmaceutical patent, TRIPS, TRIPs Agreement, UPC

(Rospatt Osten Pross )/ /10 Comments

Since the Eli Lilly v. Canada award of 2017, the relevance of international investment law for patents has been known to a wider public. In response to the revocation of two Canadian patents concerning the compounds olanzapine and atomoxetine by Canadian courts, the US pharmaceutical company Eli Lilly initiated arbitral proceedings against Canada on the…

EPO, Investment, Treasury

(Müller-Boré & Partner)/ /6 Comments

Recently, “New Investment Guidelines of the European Patent Office” (CA/F 18/17 Rev. 1) was published among the “Administrative Council documents” on the EPO web site. The Investment Guidelines relate to management of the treasury of the EPO and outline a more flexible approach for investing the funds in the treasury. In particular, rather than being…